000			02128cam a2200289zu 4500
001			88814376
003			FRCYB88814376
005			20250107211543.0
006			m o d
007			cr un
008			250107s2013 fr | o|||||0|0|||eng d
020			_a9780124071803
035			_aFRCYB88814376
040			_aFR-PaCSA _ben _c _erda
100	1		_aBartfai, Tamas
245	0	1	_aThe Future of Drug Discovery _bWho Decides Which Diseases to Treat? _c['Bartfai, Tamas', 'Lees, Graham V.']
264		1	_bElsevier Science _c2013
300			_a p.
336			_btxt _2rdacontent
337			_bc _2rdamdedia
338			_bc _2rdacarrier
650		0	_a
700	0		_aBartfai, Tamas
700	0		_aLees, Graham V.
856	4	0	_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88814376 _qtext/html _a
520			_aThe Future of Drug Discovery: Who decides which diseases to treat? provides a timely and detailed look at the efforts of the pharmaceutical industry and how they relate, or should relate, to societal needs. The authors posit that as a result of increasing risk aversion and accelerated savings in research and development, the industry is not developing drugs for increasingly prevalent diseases, such as Alzheimer’s disease, untreatable pain, antibiotics and more. This book carefully exposes the gap between the medicines and therapies we need and the current business path. By analyzing the situation and discussing prospects for the next decade, the The Future of Drug Discovery is a timely book for all those who care about the development needs for drugs for disease. This thought-provoking book is the first to: provide an in-depth, broad perspective on the crisis in drug industry expose the disconnect between what society needs and what the drug companies are working on analyse and project over 10 years into the future explain what it means for scientists and society determine what is needed to be done to make sure that the industry responds to society's needs, remains commercially attractive and answers the question as to who decides which diseases to treat
999			_c61644 _d61644